Skip to content

Insmed Inc

INSM· NasdaqCore metricsCIK 1104506

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -2.24%
Market cap
$25.90B
219.38M shares
Filings
1,052
$524.43M
Q3 2026+66.7% FY25 yoy
-$100.32M
Q3 2026N/M FY25 yoy
-$89.37M
Q3 2026N/M FY25 yoy
-$363.39M
Q3 2026derivedN/M FY25 yoy
-$0.46
Q3 2026N/M FY25 yoy
$396.56M
Q3 2026−8.0% FY25 yoy
$25.90B
—
17.0×
35.7×
-2.42%
—

Twelve months to Sep 30, 2026 · derived

Price

$118.0439.10%$75.78past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$606.42MFY 2025
$606.42M0FY 2013FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$606,423,000reported
FY 20242024-12-31$363,707,000reported
FY 20232023-12-31$305,208,000reported
FY 20222022-12-31$245,358,000reported
FY 20212021-12-31$188,461,000reported
FY 20202020-12-31$164,413,000reported
FY 20192019-12-31$136,467,000reported
FY 20182018-12-31$9,835,000reported
FY 20172017-12-31$0reported
FY 20162016-12-31$0reported
FY 20152015-12-31$0reported
FY 20132013-12-31$11,500,000reported

Segments

Revenue by Geography, FY2020 to FY2025FY2020US · FY2020 · $157.52MEurope and rest of world · FY2020 · $6.89MFY2021US · FY2021 · $159.51MEurope and rest of world · FY2021 · $12.95MJapan · FY2021 · $16.01MFY2022US · FY2022 · $185.99MEurope and rest of world · FY2022 · $2.86MJapan · FY2022 · $56.51MFY2023US · FY2023 · $224.20MInternational · FY2023 · $81.01MEurope and rest of world · FY2023 · $15.28MJapan · FY2023 · $65.73MFY2024US · FY2024 · $254.80MInternational · FY2024 · $108.91MEurope and rest of world · FY2024 · $21.21MJapan · FY2024 · $87.70MFY2025US · FY2025 · $452.95MInternational · FY2025 · $153.47M
LineFY2025ShareChange
US$452.95M75%+77.8%
International$153.47M25%+40.9%
Europe and rest of world———
Japan———
Total$606.42M

From the 10-K filed Feb 19, 2026INSM

Pharmaceutical preparations

Insmed Inc is the 51st largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Insmed Inc · CIK 1104506 · Engraved from SEC EDGAR